# Clinical Cases: Calcium and Bone Metabolism

## Case 1: Vitamin D Deficiency with Secondary Hyperparathyroidism

### Patient Demographics
- **Age:** 68 years
- **Sex:** Female
- **Occupation:** Retired nurse, now homebound

### Chief Complaint
"I've been having bone pain and feeling weak."

### History of Present Illness
A 68-year-old woman presents with a 6-month history of progressive diffuse bone pain, particularly in her back, hips, and legs. She describes generalized weakness and difficulty rising from a chair. She has had two falls in the past 3 months without significant injury. She reports limited sun exposure as she has been mostly homebound caring for her ill husband. Her diet is restricted due to lactose intolerance, and she avoids dairy products. She does not take any supplements. Past medical history includes Crohn's disease (ileal involvement, currently in remission on mesalamine) and a history of small bowel resection 10 years ago.

### Physical Examination
- **Vital Signs:** BP 128/76 mmHg, HR 72 bpm
- **General:** Thin, elderly woman in mild discomfort
- **Musculoskeletal:**
  - Tenderness over lumbar spine, pelvis, and proximal femurs
  - Proximal muscle weakness (4/5 hip flexors, difficulty standing from seated position)
  - Waddling gait
- **Skin:** No pallor
- **Neurologic:** No paresthesias, negative Chvostek and Trousseau signs

### Workup
- **Laboratory Studies:**
  - Calcium (total): 8.4 mg/dL (low-normal)
  - Calcium (ionized): 4.2 mg/dL (low-normal)
  - Phosphorus: 2.1 mg/dL (low)
  - Albumin: 3.8 g/dL (normal)
  - 25-hydroxyvitamin D: 8 ng/mL (severely deficient, normal >30)
  - 1,25-dihydroxyvitamin D: 18 pg/mL (low-normal)
  - PTH: 185 pg/mL (elevated, normal 15-65)
  - Alkaline phosphatase: 245 U/L (elevated)
  - Creatinine: 0.9 mg/dL (normal)
  - 24-hour urine calcium: 45 mg/24hr (low, indicating avid renal retention)
- **Imaging:**
  - DEXA scan: T-score -2.8 at lumbar spine, -2.6 at total hip (osteoporosis)
  - X-ray pelvis: Looser zones (pseudofractures) in bilateral pubic rami
  - X-ray spine: Diffuse osteopenia, compression deformity T12

### Diagnosis
**Severe vitamin D deficiency** with **secondary hyperparathyroidism** and **osteomalacia**

### Pathophysiology
1. Vitamin D deficiency from limited sun exposure + malabsorption (ileal resection impairs bile salt absorption needed for vitamin D uptake)
2. Low vitamin D leads to decreased intestinal calcium absorption
3. Hypocalcemia triggers compensatory PTH elevation (secondary hyperparathyroidism)
4. Elevated PTH maintains serum calcium by:
   - Increasing bone resorption (leading to bone loss)
   - Increasing renal calcium reabsorption
   - Stimulating 1-alpha-hydroxylase (though substrate limited)
5. PTH also decreases phosphorus reabsorption (causing hypophosphatemia)
6. Low calcium and phosphorus impair bone mineralization (osteomalacia)
7. Looser zones are characteristic pseudofractures of osteomalacia

### Treatment
**ACUTE REPLETION:**
1. Vitamin D3 (cholecalciferol) 50,000 IU weekly for 8 weeks
2. Calcium carbonate 1200 mg daily with meals (or calcium citrate if on PPI)
3. Monitor 25(OH)D and calcium at 8 weeks

**MAINTENANCE:**
1. Vitamin D3 2000-4000 IU daily (may need higher doses given malabsorption)
2. Calcium 1200 mg daily
3. Target 25(OH)D >30 ng/mL

**MONITORING:**
1. Recheck 25(OH)D, calcium, phosphorus, PTH at 8-12 weeks
2. Expect PTH to normalize as vitamin D replete
3. Annual DEXA to assess bone density improvement
4. Fall risk assessment and prevention

**ADDITIONAL CONSIDERATIONS:**
1. Evaluate for other fat-soluble vitamin deficiencies (A, E, K) given malabsorption
2. Consider intramuscular vitamin D if oral absorption inadequate
3. Address underlying Crohn's disease management

### Clinical Pearl
Vitamin D deficiency is extremely common, particularly in elderly, homebound individuals, those with malabsorption syndromes, and those with dark skin at northern latitudes. The appropriate physiologic response to vitamin D deficiency is elevated PTH (secondary hyperparathyroidism), which maintains serum calcium at the expense of bone health. Laboratory hallmarks include low 25(OH)D, elevated PTH, normal or low calcium, low phosphorus, and elevated alkaline phosphatase. In adults, the bone disease is osteomalacia (defective mineralization), characterized by bone pain, proximal myopathy, and Looser zones (pseudofractures) on imaging. Treatment with vitamin D and calcium will normalize PTH and allow bone remineralization. The 25(OH)D level is the best indicator of vitamin D status, as it reflects stores, whereas 1,25(OH)2D may be normal or low despite deficiency.

### Clinical Image
![Calcium Homeostasis Diagram](case_01_image.jpg)

*Diagram illustrating calcium homeostasis showing the interactions between PTH, vitamin D, and their effects on bone, kidney, and intestine to maintain serum calcium levels.*

**Image Source:** Wikimedia Commons - "Calcium regulation and parathyroid hormone"
**License:** CC BY-SA 4.0
**URL:** https://commons.wikimedia.org/wiki/File:Calcium_regulation_and_the_parathyroid_hormone.svg

---

## Case 2: Bone Remodeling - Paget Disease of Bone

### Patient Demographics
- **Age:** 72 years
- **Sex:** Male
- **Occupation:** Retired engineer

### Chief Complaint
"My leg has been aching and my left leg seems to be bowing."

### History of Present Illness
A 72-year-old man presents with progressive left leg pain over 2 years, described as a deep aching sensation that worsens with weight-bearing. He has noticed that his left leg appears to be "bowing" outward. He reports his hat size has increased, and his wedding ring no longer fits. He has some hearing loss in his left ear. He denies any recent fractures or trauma. His family history is notable for his mother having a "bone condition" that required treatment. He is otherwise healthy with well-controlled hypertension.

### Physical Examination
- **Vital Signs:** BP 136/82 mmHg, HR 70 bpm
- **General:** Well-appearing elderly man
- **Head:** Frontal bossing, increased skull circumference
- **HEENT:** Decreased hearing left ear (conductive)
- **Cardiovascular:** Hyperkinetic precordium, soft systolic murmur
- **Extremities:**
  - Left tibia: Palpable warmth over anterior surface, bowing deformity
  - Leg length discrepancy (left > right)
- **Skin:** Increased warmth over left shin

### Workup
- **Laboratory Studies:**
  - Calcium: 9.4 mg/dL (normal)
  - Phosphorus: 3.5 mg/dL (normal)
  - PTH: 42 pg/mL (normal)
  - 25-hydroxyvitamin D: 28 ng/mL (borderline low)
  - Alkaline phosphatase (total): 485 U/L (markedly elevated)
  - Bone-specific alkaline phosphatase: Elevated
  - Creatinine: 1.1 mg/dL (normal)
  - C-telopeptide (CTX): Elevated (marker of bone resorption)
- **Imaging:**
  - X-ray left tibia: Cortical thickening, mixed lytic and scite lesions, bowing deformity, anterior cortex involvement (classic "saber shin")
  - X-ray skull: Cotton wool appearance, thickened calvarium
  - Bone scan: Markedly increased uptake in left tibia, skull, and pelvis
- **Audiogram:** Conductive hearing loss left ear

### Diagnosis
**Paget disease of bone** (polyostotic)

### Pathophysiology
1. Paget disease involves accelerated, disordered bone remodeling
2. Begins with osteoclast overactivation (lytic phase) - osteoclasts are abnormally large and multinucleated
3. Followed by compensatory osteoblast activity (mixed/sclerotic phase)
4. Results in disorganized woven bone that is mechanically weak despite being thickened
5. Increased bone vascularity causes warmth and can lead to high-output cardiac state in extensive disease
6. Alkaline phosphatase reflects osteoblast activity and disease extent
7. Calcium and phosphorus remain normal because resorption and formation are coupled

### Treatment
**INDICATIONS FOR TREATMENT:**
- Bone pain
- Involvement of weight-bearing bones (fracture risk)
- Skull involvement (hearing loss, neurologic complications)
- Planned orthopedic surgery on affected bone
- Elevated alkaline phosphatase (>2x normal)
- Hypercalcemia (rare, with immobilization)

**PHARMACOLOGIC:**
1. **Bisphosphonates (first-line):**
   - Zoledronic acid 5 mg IV single dose (preferred - most potent, long remission)
   - Alternative: Alendronate 40 mg daily x 6 months
2. **Calcium and vitamin D supplementation:** 1000 mg calcium, vitamin D 800-1000 IU daily (prevent hypocalcemia with bisphosphonate)
3. **Calcitonin:** Rarely used (less effective, reserved for bisphosphonate intolerance)

**MONITORING:**
1. Alkaline phosphatase at 3-6 months (should decrease by >75%)
2. Clinical symptom assessment
3. Repeat imaging if new symptoms
4. Consider retreatment if ALP rises and symptoms recur

**COMPLICATIONS TO MONITOR:**
1. Pathologic fracture
2. Hearing loss (cochlear involvement or ossicular Paget)
3. Spinal stenosis (vertebral involvement)
4. High-output heart failure (extensive disease)
5. Osteosarcoma (<1%, suspect if sudden worsening pain)

### Clinical Pearl
Paget disease of bone is characterized by focal areas of accelerated and disordered bone remodeling, typically affecting patients over 50 years old. The hallmark laboratory finding is markedly elevated alkaline phosphatase with normal calcium and phosphorus, distinguishing it from primary hyperparathyroidism (elevated calcium) and osteomalacia (low calcium/phosphorus, elevated PTH). The disease proceeds through three phases: lytic (osteoclast predominant), mixed (both cells active), and sclerotic (osteoblast predominant). Clinical features depend on location: skull involvement causes headache, hearing loss, and increased hat size; spine involvement causes pain and spinal stenosis; long bone involvement causes pain, deformity, and fracture risk. Bisphosphonates are highly effective at suppressing disease activity, with zoledronic acid providing the longest remission. Rare transformation to osteosarcoma should be suspected if there is sudden severe pain or rapid radiographic change.

### Clinical Image
![Calcium Homeostasis Diagram](case_01_image.jpg)

*Diagram demonstrating normal calcium and bone metabolism pathways, with PTH, vitamin D, and their coordinated effects on maintaining calcium homeostasis through actions on bone, kidney, and intestine.*

**Image Source:** Wikimedia Commons - "Calcium regulation and parathyroid hormone"
**License:** CC BY-SA 4.0
**URL:** https://commons.wikimedia.org/wiki/File:Calcium_regulation_and_the_parathyroid_hormone.svg

---